Notícias Eulerpool Simcere Pharmaceutical Group

Simcere Pharmaceutical Group Notícias de ações

Simcere Pharmaceutical Group é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de Simcere Pharmaceutical Group nós reunimos aqui.

• 30 de outubro ·

  Yahoo
  World Stroke Congress | TASTE-2 significantly reduces stroke disability
• 25 de outubro ·

  Yahoo
  TASTE-2 World Stroke Congress | Sanbexin ® combined with thrombectomy significantly reduces stroke disability
• 14 de setembro ·

  Yahoo
  Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration
• 8 de setembro ·

  SeekingAlpha
  Week In Review: EpimAb Sells T-Cell Engager In $635m Deal
• 5 de setembro ·

  Yahoo
  Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration
• 2 de setembro ·

  Yahoo
  Simcere Zaiming collaborates with TargetRx to introduce a third-generation ALK inhibitor
• 26 de junho ·

  Yahoo
  Simcere Zaiming Announce Approval of Cetuximab Beta in China by the NMPA